Your browser is no longer supported. Please, upgrade your browser.
Settings
DXCM DexCom, Inc. daily Stock Chart
DXCM [NASD]
DexCom, Inc.
Index- P/E88.12 EPS (ttm)1.69 Insider Own1.10% Shs Outstand88.45M Perf Week2.03%
Market Cap13.13B Forward P/E534.14 EPS next Y0.28 Insider Trans-22.32% Shs Float87.65M Perf Month0.98%
Income148.90M PEG- EPS next Q0.17 Inst Own- Short Float6.57% Perf Quarter4.04%
Sales914.60M P/S14.36 EPS this Y182.00% Inst Trans6.05% Short Ratio3.86 Perf Half Y19.85%
Book/sh6.35 P/B23.38 EPS next Y380.00% ROA4.40% Target Price150.75 Perf Year166.40%
Cash/sh7.56 P/C19.64 EPS next 5Y- ROE9.20% 52W Range53.30 - 155.85 Perf YTD23.95%
Dividend- P/FCF206.18 EPS past 5Y23.00% ROI8.20% 52W High-4.72% Beta0.80
Dividend %- Quick Ratio4.40 Sales past 5Y48.40% Gross Margin65.00% 52W Low178.59% ATR4.94
Employees2290 Current Ratio4.70 Sales Q/Q44.50% Oper. Margin-1.10% RSI (14)59.69 Volatility3.54% 3.37%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin4.70% Rel Volume0.64 Prev Close147.83
ShortableYes LT Debt/Eq0.62 EarningsFeb 21 AMC Payout0.00% Avg Volume1.49M Price148.49
Recom1.90 SMA201.64% SMA5011.54% SMA20023.29% Volume956,036 Change0.45%
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Sep-26-17Initiated Northland Capital Outperform $85
Sep-15-17Initiated Barclays Equal Weight $76
May-22-17Resumed Piper Jaffray Overweight
May-03-17Reiterated Canaccord Genuity Buy $95 → $90
Feb-15-19 02:00PM  The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings Benzinga
Feb-14-19 10:31AM  DexCom (DXCM) Earnings Expected to Grow: Should You Buy? Zacks
07:39AM  Here's Why Investors Should Buy CONMED (CNMD) Stock Now Zacks
Feb-13-19 12:38PM  Beating the Market With Medical-Device Stocks Barrons.com
08:12AM  DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-08-19 08:58AM  Ecolab (ECL) Reports Preliminary Q4 Results, Issues Guidance Zacks
08:37AM  Can TruBridge Fuel Computer Programs' (CPSI) Q4 Earnings? Zacks
Feb-07-19 09:34AM  BD Gains From Solid Global Base, Headwinds Anticipated Zacks
08:56AM  HealthEquity's (HQY) Preliminary Q4 Results Cheer Investors Zacks
Feb-05-19 09:12AM  3 Medical Instruments Stocks Likely to Beat Estimates in Q4 Zacks
Feb-04-19 06:59PM  Cramer Remix: Apple's next move in health care could be with Dexcom CNBC
03:49PM  Why DexCom Shares Soared 17.7% in January Motley Fool
08:57AM  Will Diagnostics Business Ail LabCorp (LH) in Q4 Earnings? Zacks
Feb-03-19 09:00AM  Better Buy: Abbott Laboratories vs. DexCom Motley Fool
Jan-31-19 10:58AM  Can Boston Scientific (BSX) Q4 Earnings Fuel Overall Growth? Zacks
10:17AM  Can Molecular Diagnostics Drive Myriad's (MYGN) Q2 Earnings? Zacks
Jan-28-19 10:12AM  Cerner (CERN) to Report Q4 Earnings: What's in the Cards? Zacks
10:01AM  Can Zimmer Biomet (ZBH) Grow on Hip Business in Q4 Earnings? Zacks
09:48AM  Can CAG Growth Steadily Drive IDEXX (IDXX) in Q4 Earnings? Zacks
07:55AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q1 Earnings? Zacks
07:29AM  Will Core Business Units Boost McKesson's (MCK) Q3 Earnings? Zacks
Jan-25-19 09:10AM  ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates Zacks
08:53AM  AmerisourceBergen (ABC) Q1 Earnings: What's in the Cards? Zacks
08:12AM  What's in Store for Edwards Lifesciences' (EW) Q4 Earnings? Zacks
Jan-24-19 04:15PM  Dexcom Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for February 21, 2019 at 4:30 p.m. Eastern Time Business Wire
11:15AM  Will Flagship Impella Drive ABIOMED's (ABMD) Q3 Earnings? Zacks
11:08AM  NextGen's (NXGN) Q3 Earnings Beat Estimates, Bookings Up Y/Y Zacks
10:19AM  What's Setting the Tone for Hologic's (HOLX) Q1 Earnings? Zacks
09:56AM  Will Core Renal Care Unit Fuel Baxter's (BAX) Q4 Earnings? Zacks
09:54AM  Varian (VAR) Meets Q1 Earnings Estimates, Grows Globally Zacks
09:52AM  PetMed (PETS) Q3 Earnings Fall Y/Y, Reorder Sales Strong Zacks
02:43AM  Abbott (ABT) Q4 Earnings Meet Estimates, Organic Growth Solid Zacks
Jan-23-19 09:16AM  Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q4 Earnings? Zacks
09:13AM  Can Overall Growth Fuel Align Technology's (ALGN) Q4 Earnings? Zacks
Jan-22-19 11:55AM  DexCom, Inc. (NASDAQ:DXCM): Time For A Financial Health Check Simply Wall St.
08:13AM  ResMed Launches Nasal Mask Devise, Extends AirFit Portfolio Zacks
Jan-21-19 07:56AM  Will Core MedSurg Segment Aid Stryker's (SYK) Q4 Earnings? Zacks
Jan-20-19 10:15AM  3 Healthcare Stocks Hitting 52-Week Highs: Are They Buys? Motley Fool
Jan-16-19 10:00AM  Here's Why Momentum Investors Will Love DexCom (DXCM) Zacks
Jan-15-19 09:30PM  3 Top Diabetes Stocks to Watch in January Motley Fool
09:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
08:56AM  Will Instruments Fuel Intuitive Surgical (ISRG) Q4 Earnings? Zacks
06:09AM  Varian Medical (VAR) to Report Q1 Earnings: What's in Store? Zacks
Jan-11-19 07:52AM  3 Medical Services Stocks to Buy in 2019: HQY, AMEH & OPGN Zacks
Jan-09-19 07:09PM  CEO of glucose monitor maker Dexcom says company has 'pri... CNBC Videos +5.50%
02:00PM  Here's Why DexCom Skyrocketed 109% in 2018 Motley Fool
Jan-08-19 04:58PM  Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018 Motley Fool
Jan-07-19 05:02PM  Here's Why DexCom Traded 11.8% Higher Today Motley Fool +11.79%
09:35AM  AngioDynamics (ANGO) Q2 Earnings Beat on Gains From NanoKnife Zacks
07:30AM  Dexcom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2018 and Provides Initial 2019 Outlook Business Wire
Jan-03-19 09:00AM  Here's Why Investors Should Bet on DexCom (DXCM) Right Now Zacks
08:30AM  IOT Set for Explosive Growth, These Stocks Will Benefit ACCESSWIRE
Jan-02-19 02:40PM  Here's Why Tandem Diabetes Care Is Dropping Today Motley Fool
Dec-27-18 09:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
Dec-24-18 06:33AM  DexCom Sees Hammer Chart Pattern: Time to Buy? Zacks
Dec-19-18 08:49AM  4 Healthcare Stocks That Popped More Than 100% in 2018 Zacks
Dec-18-18 04:01PM  Dexcom Announces Upcoming Conference Presentation Business Wire
Dec-17-18 09:02AM  Are ABMD & DXCM Neck and Neck? Let's Take a Closer Look Zacks -5.77%
08:36AM  4 Medical Device Stocks That More Than Doubled in 2018 Zacks
Dec-12-18 11:49AM  3 Top Medical Device Stocks to Buy Now Motley Fool
08:25AM  5 Stocks That Popped More Than 100% in 2018 Defying All Odds Zacks
Dec-11-18 12:57AM  Hedge Funds Are Betting On DexCom, Inc. (DXCM) Insider Monkey
Dec-10-18 09:30AM  Has DexCom (DXCM) Outpaced Other Medical Stocks This Year? Zacks
08:40AM  What Falling Estimates & Price Mean for Alphatec Holdings (ATEC) Zacks
Dec-05-18 09:23AM  2 Internet of Things Stocks to Buy for the Connected Future InvestorPlace
Dec-04-18 07:00AM  Today's Research Reports on Trending Tickers: DexCom and BioTelemetry ACCESSWIRE -6.35%
Nov-29-18 08:15AM  Detailed Research: Economic Perspectives on Broadridge Financial Solutions, MercadoLibre, Rogers, Ensco plc, Liberty Oilfield Services, and DexCom What Drives Growth in Today's Competitive Landscape GlobeNewswire
06:31AM  5 Stocks to Gain as Fed Chair "Blinks" on Rates Zacks
Nov-28-18 08:16AM  Zacks.com highlights: DexCom, E*TRADE Financial, MCBC Holdings and Quidel Zacks
06:30AM  DexCom Prices Offering of $750.0 Million of 0.75% Convertible Senior Notes Business Wire
Nov-27-18 06:43AM  4 Profitable Stocks Boasting Amazingly High Net Income Ratio Zacks
Nov-26-18 04:15PM  DexCom Announces Proposed Offering of $750 Million of Convertible Senior Notes Business Wire
09:46AM  Here's Why Investors Should Bet on DexCom (DXCM) Right Now Zacks
Nov-22-18 09:18AM  DexCom Amends Deal With Verily to Launch Advanced CGM by 2020 Zacks
Nov-21-18 09:27AM  How Should Investors Feel About DexCom Incs (NASDAQ:DXCM) CEO Pay? Simply Wall St.
08:30AM  DexCom Announces Upcoming Conference Presentation Business Wire
08:04AM  The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO Benzinga
Nov-20-18 05:12PM  Dexcom and Verily Amend Collaboration and License Agreement Business Wire
Nov-19-18 10:00AM  Alphabet Halts Glucose Lens Work to Focus on Other Projects Zacks -12.19%
Nov-16-18 04:32PM  DexCom Stock Could Continue to Climb Investopedia
Nov-13-18 06:09AM  DexCom (DXCM) Beats Q3 Earnings Estimates, Raises '18 View Zacks
Nov-12-18 07:00AM  Today's Research Reports on Trending Tickers: DexCom and BioTelemetry ACCESSWIRE -5.12%
Nov-09-18 09:01AM  3 Growth Stocks Healthcare Investors Should Buy Now Motley Fool
Nov-08-18 04:14PM  IBD Stock Of The Day Flirts With Breakout And Nears Annual Profitability Investor's Business Daily
08:51AM  DexCom (DXCM) Catches Eye: Stock Jumps 8.8% Zacks
Nov-07-18 05:30PM  Dexcom to Host Investor Day on December 4, 2018 Business Wire +8.82%
05:30AM  Edited Transcript of DXCM earnings conference call or presentation 6-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-06-18 05:15PM  DexCom (DXCM) Tops Q3 Earnings and Revenue Estimates Zacks
04:10PM  DexCom: 3Q Earnings Snapshot Associated Press
04:01PM  DexCom Reports Third Quarter 2018 Financial Results Business Wire
Nov-02-18 02:41PM  7 Straight-A Stocks to Build a Portfolio Around InvestorPlace
Oct-22-18 07:45AM  Detailed Research: Economic Perspectives on DexCom, MiX Telematics, Resolute Forest Products, Equinix, Johnson & Johnson, and Vedanta What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-18-18 10:52AM  DexCom Launches CLARITY Mobile App, Strengthens CGM Profile Zacks
08:00AM  Dexcom G6® Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries with Diabetes in Early 2019 Business Wire
Oct-11-18 04:00AM  Dexcom Announces Release of Clarity Mobile App PR Newswire
Oct-09-18 09:24AM  The Zacks Analyst Blog Highlights: Masimo, Medtronic, Garmin and DexCom Zacks
Oct-08-18 08:30AM  Wearable Medical Device Boom Puts These 3 Stocks in Focus Zacks
08:00AM  DexCom Schedules Third Quarter 2018 Earnings Release and Conference Call for November 6, 2018 at 4:30 p.m. Eastern Time. Business Wire
Oct-04-18 09:49AM  US Diabetes Market Gaining Momentum: 3 Stocks in Focus Zacks
Sep-27-18 11:33AM  Investing in Diabetes Stocks: A Beginner's Guide Motley Fool
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAYER KEVIN RPresident, CEO and ChairmanFeb 11Sale148.906,000893,400308,837Feb 13 07:23 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 09:24 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 04:46 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 23Sale149.743,114466,303101,404Jan 24 05:46 PM
SAYER KEVIN RPresident, CEO & ChairmanJan 14Sale140.996,000845,930314,837Jan 15 05:30 PM
KAHN BARBARADirectorJan 14Sale142.3010,6311,512,82716,817Jan 16 06:08 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffJan 10Sale138.7540055,50029,708Jan 14 09:42 PM
SKYLER JAY SDirectorJan 02Option Exercise4.5825,806118,19152,616Jan 04 05:03 PM
ALTMAN STEVEN RDirectorJan 02Sale117.042,500292,59352,855Jan 04 05:03 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerDec 21Sale109.341,510165,10114,112Dec 26 08:33 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Dec 21Sale109.413,114340,700104,518Dec 26 08:22 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalDec 14Sale121.235,000606,16773,105Dec 18 06:34 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Option Exercise4.5811,16251,122331,999Dec 12 09:08 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffDec 10Sale121.9040048,76030,108Dec 12 09:09 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Sale121.6711,1621,358,041320,837Dec 12 09:08 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerNov 23Sale121.351,736210,66415,622Nov 27 06:27 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 23Sale121.423,114378,105107,632Nov 27 06:27 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalNov 14Sale143.135,000715,66478,105Nov 16 05:14 PM
SAYER KEVIN RPresident, CEO & ChairmanNov 12Option Exercise4.5811,16151,117331,998Nov 14 07:29 PM
SAYER KEVIN RPresident, CEO & ChairmanNov 12Sale146.4311,1611,634,284320,837Nov 14 07:29 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffNov 09Sale148.1140059,24430,508Nov 13 08:14 PM
Abbey DonaldEVP, Quality & Regulatory AfrsNov 09Sale149.3010,5501,575,15988,089Nov 13 08:13 PM
ACE HEATHER SSVP Human ResourcesNov 09Sale147.324,258627,29465,081Nov 13 08:14 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Oct 23Sale128.853,114401,253110,746Oct 25 08:58 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerOct 23Sale128.721,736223,46617,358Oct 25 08:59 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalOct 12Sale124.795,000623,93483,105Oct 16 05:27 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffOct 10Sale122.2040048,88030,908Oct 12 04:11 PM
SAYER KEVIN RPresident, CEO & ChairmanOct 08Option Exercise4.5811,16151,117331,998Oct 10 07:48 PM
SAYER KEVIN RPresident, CEO & ChairmanOct 08Sale124.7611,1611,392,433320,837Oct 10 07:48 PM
ALTMAN STEVEN RDirectorOct 01Sale135.652,500339,13455,355Oct 03 04:50 PM
Leach Jacob StevenChief Technology OfficerSep 28Sale143.9547,6006,852,1390Oct 01 07:10 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 24Sale141.201,736245,12919,094Sep 26 08:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 24Sale141.253,114439,841113,860Sep 26 08:32 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 14Sale145.175,000725,85188,105Sep 18 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 12Option Exercise5.9215,00088,800109,284Sep 14 04:35 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 11Sale147.048,4401,241,02887,131Sep 13 09:48 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Option Exercise4.5811,16151,117346,332Sep 12 09:17 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 10Sale143.765,483788,21066,804Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.355,736822,25616,711Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.764,594660,41163,920Sep 12 09:22 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrSep 10Sale143.692,372340,82531,308Sep 12 09:20 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 10Sale143.765,483788,210116,974Sep 12 09:21 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 10Sale143.765,587803,16093,105Sep 12 09:21 PM
ACE HEATHER SSVP Human ResourcesSep 10Sale143.761,832263,36069,339Sep 12 09:19 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 10Sale143.764,614663,28694,284Sep 12 09:20 PM
Abbey DonaldEVP, Quality & Regulatory AfrsSep 10Sale143.762,303331,06898,639Sep 12 09:19 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 10Sale143.767,1491,027,70695,571Sep 12 09:18 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Sale143.6225,4953,661,573320,837Sep 12 09:17 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Option Exercise4.5220,57792,941109,455Aug 28 06:58 PM
ALTMAN STEVEN RDirectorAug 24Sale136.475,000682,3590Aug 28 08:32 PM
FOLETTA MARK GDirectorAug 24Sale137.501,000137,50317,095Aug 28 07:01 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Sale138.3220,5772,846,15598,878Aug 28 06:58 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 23Sale139.963,114435,843122,457Aug 27 05:20 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerAug 23Sale140.032,584361,8330Aug 27 05:20 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalAug 14Sale124.255,000621,25398,567Aug 16 06:08 PM
SAYER KEVIN RPresident, CEO & ChairmanAug 13Option Exercise4.5811,16151,117346,332Aug 15 05:15 PM
SAYER KEVIN RPresident, CEO & ChairmanAug 13Sale123.2211,1611,375,211335,171Aug 15 05:15 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrAug 10Sale124.1812,5001,552,31033,680Aug 14 08:32 PM
AUGUSTINOS NICHOLASDirectorAug 06Sale121.773,230393,30114,362Aug 08 08:33 PM
AUGUSTINOS NICHOLASDirectorAug 06Sale121.189,0701,099,0807,802Aug 08 08:33 PM
MOY JEFFREYSVP, OperationsAug 01Sale94.135,831548,8725,061Aug 03 04:50 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jul 25Sale101.913,114317,335125,571Jul 27 05:09 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJul 23Sale102.482,581264,5131,067Jul 25 07:54 PM
GREGG TERRANCE HExecutive ChairmanJul 16Sale99.5610,000995,56150,882Jul 18 05:50 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalJul 16Sale99.565,000497,816103,567Jul 18 05:50 PM
SAYER KEVIN RPresident & CEOJul 09Sale99.7914,2191,418,856335,171Jul 11 09:07 PM
MOY JEFFREYSVP, OperationsJun 28Sale92.4859,1935,474,29710,892Jul 02 08:51 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJun 25Sale98.582,581254,4313,648Jun 26 08:26 PM
GREGG TERRANCE HExecutive ChairmanJun 15Sale97.8110,000978,096882Jun 19 08:37 PM
TOPOL ERICDirectorJun 12Sale100.1020,0002,001,99884,562Jun 13 08:19 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerMay 23Sale86.002,581221,9636,229May 25 07:52 PM
GREGG TERRANCE HExecutive ChairmanMay 15Sale85.9010,000858,974882May 17 06:49 PM
SKYLER JAY SDirectorMay 14Option Exercise4.5830,000137,40052,257May 16 08:00 PM
SKYLER JAY SDirectorMay 14Sale88.0030,0002,640,00022,257May 16 08:00 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.May 10Option Exercise7.632,85521,784128,685May 11 08:03 PM
SAYER KEVIN RPresident & CEOMay 09Option Exercise7.6331,464240,070366,635May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 09Option Exercise9.728,74585,017107,420May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 09Sale84.778,745741,32898,878May 10 07:54 PM
SAYER KEVIN RPresident & CEOMay 09Sale84.3717,2451,454,992349,390May 10 07:54 PM
SKYLER JAY SDirectorMay 08Option Exercise7.6331,464240,07053,721May 09 08:22 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 08Option Exercise3.191,9236,134100,801May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 08Sale85.152,500212,87447,600May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 08Sale84.951,923163,36698,878May 10 07:54 PM
SKYLER JAY SDirectorMay 08Sale85.1131,4642,678,02422,257May 09 08:22 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerApr 23Sale73.092,581188,6498,810Apr 25 07:33 PM
GREGG TERRANCE HExecutive ChairmanApr 16Sale73.0410,000730,414882Apr 18 07:24 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerMar 23Sale68.442,581176,64311,391Mar 27 06:54 PM
GREGG TERRANCE HExecutive ChairmanMar 15Sale65.5110,000655,12210,882Mar 19 08:08 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerFeb 23Sale56.321,63892,25213,972Feb 27 05:32 PM